BioWorld - Sunday, January 25, 2026

BioWorld Science

April 13, 2022

View Archived Issues

FGFR2-selective inhibitor CGT-0292 shows promise for treating hyperphosphatemia

Read More

Lieber Institute, Johns Hopkins University present DNA-directed RNA polymerase I inhibitors

Read More

New protein kinase inhibitors described by Voronoi, B2SBIO and Voronoi Bio

Read More

Kinnate Biopharma discovers RAF kinase inhibitors

Read More

Asan Foundation, DGMIF, University of Ulsan describe new EHMT2 inhibitors

Read More

Neuropilin-2 suppression is possible approach for treating lymphatic malformations

Read More

In vivo imaging of integrin beta-2 activation enabled with humanized integrin beta-2 knockin mice

Read More

CFT-8634, a novel BRD9 degrader with promising efficacy in PDX models of synovial sarcoma

Read More

AACR 2022: Understanding cancer's brain is new microenvironment frontier

Read More

Preclinical evaluation of EPC-001, a fully human anti-CD19 and CD22 bispecific tandem CAR-T

Read More

GCN2 is activated in prostate cancer and shows promise as therapeutic target

Read More

Gb Sciences' cannabinoid-containing formulations to be tested in rodent models of Parkinson's

Read More

MYMD-1 shows anti-inflammatory effects in comparative study in rheumatoid arthritis model

Read More

ABN-501, a novel antibody targeting CLDN3, for cancer immunotherapy

Read More

Engitix expands collaboration with Takeda to include therapeutics for fibrostenotic IBD

Read More